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Available online 12 June 2011Abstract The purpose of this work was to investigate if a coculture system of human mesenchymal stem cells (hMSC) with
endothelial cells (human umbilical vein endothelial cells, HUVEC) could modulate the phenotype and proliferation of
harvested MSCs. In addition to previous investigations on the crosstalk between these two cell types, in the present work
different relative cell ratios were analyzed for long, therapeutically relevant, culture periods. Moreover, MSCs osteogenic
commitment was assessed in a non-osteogenic medium and in the presence of HUVECs through magnetic cell separation, cell
quantification by flow cytometry, morphology by fluorescent microscopy, metabolic activity and gene expression of
osteogenic markers. Collectively, the present findings demonstrate that, by coculturing MSCs with HUVECs, there was not only
the promotion of osteogenic differentiation (and its enhancement, depending on the relative cell ratios used), but also a
significant increase on MSCs proliferation. This augmentation in cell proliferation occurred independently of relative cell
ratios, but was favored by higher relative amounts of HUVECs. Taken together, this data suggests that HUVECs not only
modulate MSC phenotype but also their proliferation rate. Therefore, a coculture system of MSCs and HUVECs can a have a
broad impact on bone tissue engineering approaches.
© 2011 Elsevier B.V. All rights reserved.Introduction
Mesenchymal stem cells (MSCs) represent an adherent,
fibroblast-like population present not only in bone marrow,⁎ Corresponding author at: INEB-Instituto de Engenharia Biomé-
dica, Rua do Campo Alegre, 823, 4150–180 Porto, Portugal. Fax:
+351 226094567.
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doi:10.1016/j.scr.2011.05.006but also in a number of other tissues, including blood, adipose
tissue, muscle and dermis (Sotiropoulou et al., 2006). In bone
tissue engineering approaches, bone marrow MSCs have
demonstrated great potential for the treatment of bone loss,
fracture non-union and osteogenesis imperfecta (Bajada et al.,
2008; Sensebé et al., 2009). The success of bone regeneration
strategies is in part based in the reintroduction of in vitro
expanded cells in a state that guarantees their differentiation
into functional bone matrix-producing cells (Hofmann et al.,.
187Phenotypic and proliferative modulation of hMSC via crosstalk with endothelial cells2008). MSCs differentiated into the osteogenic lineage
represent thus an appealing source of adult stem cells for
bone tissue engineering applications (Moioli et al., 2007).
However, these approaches find limitations in the
considerably low percentage of MSCs in adult bone marrow,
and the vast numbers required for therapeutic approaches
(Sot\iropoulou et al., 2006; Shahdadfar et al., 2005). The
identification of mechanisms involved in stem cells self-
renewal and differentiation is important for the design of
new strategies to expand stem cells in vitro and modulate
their phenotype. MSCs fate decision can be regulated by
exogenous soluble growth factors, cytokines, hormones and
chemicals and by external mechanical forces (Alsberg et al.,
2006). Another approach to guide MSCs fate relies in the
coculturing with other mature cell populations (Ball et al.,
2004). Ball and co-authors demonstrated that MSC are
profoundly influenced by other cell types in direct contact
(Ball et al., 2004). Among these, endothelial cells (ECs) have
been shown to express several factors, such as BMP-2, that
induce osteogenic differentiation in vitro, when in direct
contact with bonemarrow stromal cells (Kaigler et al., 2005;
Guillotin et al., 2004). Moreover, Villars and colleagues
(2002) showed that intercommunication between ECs and
osteoblast-like cells is dependent not only on diffusible
factors but also on gap junctions (connexin 43) that play a
crucial role in cell differentiation, which points to the need
of cell-cell contact (Villars et al., 2002; Grellier et al.,
2009a). Overall, two main dialogues were identified: a
paracrine effect through VEGF, BMP-2, IGF production and a
juxtacrine mechanism by gap junctional activity between
the two cell types (Grellier et al., 2009b; Clarkin et al.,
2008a).
Although several works have been evaluating the influence
of a number of parameters for large-scale production of MSCs,
such as cell source, age, density, passage number, medium
composition, presence of growth factors and serumchoice, the
concept of using cocultures for MSCs expansion, in particular
with ECs, seems to constitute a promising approach for bone
regeneration applications and is far from being completely
investigated (Sotiropoulou et al., 2006; Shahdadfar et al.,
2005; Diascro et al., 1998; Both et al., 2007; Wall et al., 2007;
Walsh et al., 2001; Tamama et al., 2006).
The objective of this work was to investigate if a
synergistic coculture system of MSCs with endothelial cells
could affect the number and state of differentiation of
harvested MSCs. In contrast to other papers, in this cell-cell
communication topic, the investigation was carried out for a
longer time, 3 weeks instead of 1 to 6 days and different
ratios of both cell types were considered (Guillotin et al.,
2004; Villars et al., 2002; Grellier et al., 2009a; Guillotin et
al., 2008; Finkenzeller et al., 2006; Stahl et al., 2004;
Wenger et al., 2004; Villars et al., 2000; Xue et al., 2009).
Additionally, several media were tested and MSCs osteo-
genic commitment in a non-osteogenic medium in the
presence of ECs was carefully analyzed. The present results
demonstrated that, independently of the relative cell ratio
used, the coculture system promotes a significant increase
in MSCs proliferation and differentiation. Furthermore,
these results indicate that, for tissue engineering applica-
tions requiring a large number of MSCs committed into the
osteogenic lineage, a coculture system with endothelial
cells could be advantageous.Results
Selection of base medium
HUVECs and MSCs behavior was evaluated in several
commercial media, including Iscove Modified Dulbecco
Medium (IMDM), Medium 199 (M199), Dulbecco's Modified
Eagle's medium (DMEM) and a mixture 1:1 of the last two
media. The three media present some major differences in
terms of composition, (composition provided by the manu-
facturer). For instance, IMDM and M199 have a higher number
of amino acids than DMEM. IMDM has the highest glutamine
concentration, followed by DMEM and then M199. Addition-
ally, M199 has the lowest concentrations on vitamins and the
other two have a similar composition. In the inorganic salts
content, such as calcium, chlorine, iron, potassium, nomajor
differences were found. Regarding other components,
IMDM is the only with HEPES (5958 mg/L) and presents a
D-Glucose concentration (4500 mg/L) higher than the others
(1000 mg/L). Moreover, M199 does not have sodium pyruvate
in its composition.
To evaluate the effect of the different media on cell
behavior, metabolic activity and protein quantification
assays were carried out (Fig. 1). Overall, there was a
continuous increase in terms of the metabolic activity and
protein content along the time, for both HUVECs and MSCs, in
all the media tested. However, the medium that showed the
best results was different in both cell types. Considering both
assays, for HUVECs the following profile could be outlined:
IMDMNM199=M199+DMEMNDMEM. For MSCs the following
sequence was obtained: M199+DMEMNDMEMN IMDM=M199.
In a coculture approach, the selected medium should take
into consideration the behavior of both cell types. Collec-
tively, the described data pointed towards the selection of
the combined medium M199+DMEM, which provided a
performance close to the ideal in both situations.Coculture study: cell quantification, morphology
and differentiation
Cocultures were established by seeding the two different cell
types in direct contact at a cell ratio of 1:1. Both cell types
were cultured (in mono- and coculture) in the selected
medium, and the evolution on the number of total cells
along the time was analyzed, as depicted in Fig. 2. Cells in
coculture exhibited, as a whole, a significant increase in
number throughout the culture, reaching from day 14 values
significantly higher than any of the monocultures, and
continued to proliferate along the last week (Fig. 2A).
When both cell types were analyzed in separate, it could be
seen that while the number of MSCs in monoculture signifi-
cantly increased until day 14th and then remained practically
unchanged, the MSCs in coculture (CoMSCs) increased in
number throughout the 21 days (Fig. 2C). Moreover, CoMSCs
presented higher proliferation rate than MSC in monoculture
(at 1.5 x103 or 3 x103 cells/cm2) in the last two weeks of
culture. MSCs in coculture increased rapidly, reaching approx-
imately 80% of the cells in coculture after 1 week, and then
cells continued to proliferate until the end of the culture,
reaching a percentage of 94% (Fig. 2B).
Figure 1 (A,B)Metabolic activity and (C,D) protein concentration of (A, C) humanumbilical vein endothelial cells and (B,D)mesenchymal
stem cells cultured under four differentmedia: M199, M199with DMEM, DMEM and IMDM. The initial cell seeding density was the same in all
the conditions (3x103 cells/cm2). Data are expressed as mean±standard deviation (n=3). (* p≤0.05; ** p≤0.01; *** p≤0.001).
Figure 2 Mesenchymal stem cells (MSC) and human umbilical vein endothelial cells (HUVEC) cultured in mono- and coculture during
21 days. (A) Total cell number of MSC, HUVEC and coculture of both cell types; (B) Relative number of MSC (CoMSC) and HUVEC (CoHUVEC)
in the coculture; (C) Fold increase in cell number relative to day 0 of MSC in the coculture (CoMSC 1500; 1500 cells/cm2 of MSCs with 1500
cells/cm2 of HUVECs), MSC in monoculture with a cell density of 3000 cells/cm2 (MSC 3000), and MSC inmonoculture with a cell density of
1500 cells/cm2 (MSC 1500); (D) Fold increase in cell number relative to day 0 of HUVEC inmono- and co-culture during 21 days. Cocultures
were established by seeding the two cell types in direct contact at a cell ratio of 1:1with a final cell seeding density of 3x103 cells/cm2 and
the medium used (mixture 1:1 of DMEM and M199) was the same in all the conditions tested. For monocultures cell density was of 3x103
cells/cm2 with the exception of MSC 1500. Data are expressed as mean±standard deviation (n=3). (* p≤0.05; *** p≤0.001).
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rate than the MSCs on the 1st week of culture (Fig. 2A).
However, the number of cells significantly decreased
thereafter. Although the percentage of HUVECs in cocul-
ture (CoHUVECs) progressively declined, cells continued to
proliferate during the 2nd week (Fig. 2D).
The cell morphology study, revealed evident differences
between cells organization in MSCs mono- and cocultures,
as can be depicted in Fig. 3A. MSCs in monoculture
appeared randomly distributed at the cell culture surface
along the first 2 weeks, revealing, at day 21, a fibroblastic-
like shape with stress fibers running in parallel according to
cell orientation. In coculture, cells were rearranged in a
significantly different manner, forming a kind of tubular-
like cellular network. This type of structure becomes less
evident along the time, as the cell density rose. At day 21, it
was possible to visualize a crisscrossed pattern of actin
cytoskeleton with thick stress fibers.
Differences in cells morphology were also evident on the
ALP cytochemical analysis (Fig. 3B). However, in cocultures it
was possible to detect a much higher amount of ALP positive
cells in all time points. For instance, at day 14, the wells from
the coculture revealed an almost monochromatic (pink)Figure 3 (A) Immunocytochemistry of actin filaments (green) and
MSCs cultured alone or cocultured with HUVECs at different time
seeding the two different cell types together at a cell ratio of 1:1 wit
to 200 μm. Data are expressed as mean±standard deviation (n=3).surface. These results were further corroborated by the ALP
colorimetric assay (Fig. 3C). ALP activity, normalized to total
protein concentration, reached significantly higher levels in
coculture than in monoculture. In monoculture the levels of
ALP remained low and constant throughout the culture and
always below the values reached in coculture.
As previously described, the two types of cells in coculture
were separated and additional differentiation studies were
performed using only the MSC fraction. The gene expression
profile of several osteogenic markers was analyzed (Fig. 4).
The gene profile for ALP and COL I revealed a significant
difference between MSC in monoculture and cocultured MSC
(CoMSC) (for ALP pb0.05 and for type I collagen p=0.01). Runx
2 and BSP presented a significant increase after one week of
culture in CoMSC. The late-stage osteogenic differentiation
marker, OCN, even after 21 days of culture did not show
significant differences between MSC and CoMSC.Effect of different cell ratios on MSC behavior
In order to evaluate the effect of MSCs and HUVECs relative
ratios on MSCs behavior, the following combinations werenuclei (blue) and (B) ALP histochemistry and (C) ALP activity in
points under basal conditions. Cocultures were established by
h a final cell seeding density of 3x103 cells/cm2. Bars correspond
(* p≤0.05; *** p≤0.001).
Figure 4 Gene expression levels of osteogenic markers of mesenchymal stem cells (MSC) growing in monoculture and in coculture
with endothelial cells (CoMSC) by qPCR. (A) type I collagen (COL I), (B) alkaline phosphatase (ALP) and (C) bone sialoprotein (BSP) and
transcription factor Runx2 at day 7 and osteocalcin (OCN) at day 21. To perform gene analysis on CoMSC, cells were separated by
magnetic cell sorting using magnetic beads coupled with an antibody against CD31. CoMSC presented significantly higher expression
levels for COL I and ALP than MSCs in monoculture (collagen type I p=0.01 and ALP pb0.05). The experiment was performed three
times, each in triplicate. (** p≤0.01; *** p≤0.001).
190 S.J. Bidarra et al.tested: 25%HUVEC-75%MSC, 50%HUVEC-50%MSC and 75%
HUVEC-25%MSC. MSCs monocultures were used as a control.
The influence of endothelial cells on the metabolic activity,
proliferation and osteogenic differentiation of MSCs was
analyzed.
Concerning metabolic activity (Fig. 5A), the three different
ratios presenteda significant increasealong the first 2 weeks of
culture, followed by a plateau, although the MSC monoculture
showed the highest fold increase after 1 week. During the 2nd
and 3 rd weeks this behavior changed, and cells in cocultureFigure 5 (A) Metabolic activity, relative to day 1, of mesenchym
umbilical vein endothelial cells (HUVEC) and (B) the percentage of b
tested using different relative cell ratios: 25% HUVEC with 75% MSC
HUVEC with 25% MSC (75EC:25MSC). Independently of the cell ratio,
Thus, the used percentage for each cell type in the coculture was rela
assessed using the resazurin-based assay and relative quantification
standard deviation (n=3).reached metabolic activity values significantly higher than the
monoculture, at all the ratios tested. Among the different
ratios, the combination 50%HUVEC-50%MSC was the one that
presented the highest increase, although not significantly
different from the others.
The evolution of the number of cells along the time is
depicted in Fig. 5B, showing that in all the three ratios tested,
the percentage of MSCs increased, while the relative amount
of HUVECs decreased. In fact, MSCs were able to proliferate
throughout the 21 days of culture and the ratio that showedal stem cells (MSC) in monoculture or in coculture with human
oth cell types in the coculture during 21 days. Cocultures were
(25EC:75MSC), 50%HUVEC with 50% MSC (50EC:50MSC) and 75%
cocultures have also the same final density of 3x103 cells/cm2.
ted to this final value of 3x103 cells/cm2. Metabolic activity was
was obtained by flow cytometry. Data are expressed as mean±
191Phenotypic and proliferative modulation of hMSC via crosstalk with endothelial cellsthe highest MSCs proliferation was the one that started with a
lower percentage of MSCs (75%HUVEC-25%MSC). Moreover, in
this ratio, HUVECs presented the lowest decline.
To analyze MSCs differentiation in the coculture systems,
ALP activity was measured weekly for a 3 weeks period, as
illustrated in Fig. 6. Under basal conditions (Fig. 6A), MSCs in
monoculture kept a similar low value (practically null)
throughout the time, without significant variations. However,
in the presence of HUVECs, there was an increase on the ALP
activity. Although the cocultures showed the highest values,
only in the last week they reached values significantly higher
than those obtained inmonoculture. The ratios 25%HUVEC-75%
MSC and 50%EC-50%MSC were the ones resulting in the highest
ALP activity values. Under osteogenic conditions, MSCs
monoculture showed a significant increase on ALP activity
during the 1st week reaching then a plateau (Fig. 6B). In
general, in the first 2 weeks of culture, the three relative ratios
tested did not present significant ALP differences between
them. In the last week there was a significant upregulation in
ALP activity in all the cocultures, with values significantly
higher than the MSCs monoculture.
When comparing osteogenic with basal conditions, ALP
activity values were not very different but were in general
slightly higher in the former. Additionally, all the ratios tested
achieved significantly higher ALP activity values than the
monoculture.
Cytochemical stainings of ALP activity and mineralization
nodules are presented in Fig. 7, and provide additional
qualitative evidence that cells differentiated along the
osteoblastic lineages at all ratios tested.Discussion
A large number of MSCs committed to the osteogenic lineage is
necessary for creating a tissue-engineered implant able to fill
bone defects. It is generally accepted that MSCs play a critical
role in bone tissue regeneration due to their differentiation
capacity into distinct end-stage cell types, immunosuppressive
properties and ability to produce a broad spectrum ofFigure 6 Alkaline phosphatase activity of mesenchymal stem cell
endothelial cells (HUVEC) at different relative cell ratios under (
expressed in nmol per min per mg of protein. Cocultures were tes
(25EC:75MSC), 50% HUVEC with 50% MSC (50EC:50MSC) and 75% HUV
cocultures were also prepared at a total density of 3x103 cells/cm
reference to that density. Data are expressed as mean±standard debioactive macromolecules that are capable of establishing a
regenerative microenvironment (Turnovcova et al., 2009). In
bone marrow, MSCs represent a very small fraction of all
nucleated cells: less than 0.01% (Bartmann et al., 2007; Lee &
Park, 2009).
As previously pointed out, this study focused on the use of a
MSCs-endothelial cells coculture system as a strategy to
modulate MSCs expansion and osteogenic differentiation in
vitro. Our team is specifically interested in addressing this
subject in the context of a minimally invasive bone regener-
ation strategy using injectable 3Dmatrices (Evangelista et al.,
2007; Grellier et al., 2009c; Bidarra et al., 2010; Fonseca et
al., 2011; Munarin et al., 2011). As reviewed by Grellier and
colleagues (2009) there are some studies on the reciprocal
regulation and functional relationship between bone and
endothelial cells which, in turn, may be greatly influenced by
the culture conditions (Grellier et al., 2009b).
In a preliminary phase of the present study, and due to its
impact in future cell studies, the appropriate medium for the
coculture system was established. It is worth mentioning that,
due to the dramatic influence that the batch of serummay have
on MSCs behavior at different levels (proliferation, differenti-
ation and gene expression) (Shahdadfar et al., 2005), a previous
serum batch-selectionwasmade and it was used to supplement
all the tested media. Media selection was based on cell
metabolic activity, total protein content and optical microsco-
py analyzes (Fig. 1). The tested media included those routinely
used to culture the two cell types in monoculture (DMEM and
M199 for MSCs and HUVECs, respectively) and also IMDM, a
medium reported in several works for expansion and further
coculture of both cell types (Guillotin et al., 2004; Villars et al.,
2002; Grellier et al., 2009a; Guillotin et al., 2008; Villars et al.,
2000; Meury et al., 2006). In several other studies, the medium
selected for the cocultures was the same one used for ECs
monocultures (Finkenzeller et al., 2006; Stahl et al., 2004;
Wenger et al., 2004; Fuchs et al., 2009a; Fuchs et al., 2007;
Fuchs et al., 2009b; Santos et al., 2009; Stahl et al., 2005;
Unger et al., 2007; McEwen et al., 2003). Here, the medium
selected was a DMEM+M199 mixture (1:1). After one week of
culture, the cell performance in the presence of this mediums (MSC) cultured alone or cocultured with human umbilical vein
A) basal conditions and (B) osteogenic conditions. Results are
ted at different relative cell ratios: 25% HUVEC with 75% MSC
EC with 25% MSC (75EC:25MSC). Independently of the cell ratio
2, and the percentage for each cell type was calculated with
viation (n=3). (* p≤0.05; ** p≤0.01; *** p≤0.001).
Figure 7 Alkaline phosphatase activity (ALP) and von Kossa (vK) histochemistry in cocultures after 21 days, under basal conditions
(BC) and osteogenic conditions (OC). Cocultures were tested at different relative cell ratios: 25% HUVEC with 75% MSC (25EC:75MSC),
50% HUVEC with 50% MSC (50EC:50MSC) and 75% HUVEC with 25% MSC (75EC:25MSC). Independently of the cell ratio cocultures were
also prepared at a total density of 3x103 cells/cm2, and the percentage for each cell type was calculated with reference to that
density. Bars correspond to 200 μm.
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and HUVECs, respectively. Moreover, by choosing this mixed
medium, cells in coculture will continue to be in contact with
their expansion medium.
Several published studies on this topic provide insights into
the relationship between the two cell types but there is still a
limited knowledge concerning the proliferation behavior of
cells in coculture. For a detailed analysis on cell proliferation
in coculture, immunomagnetic beads coupled with an anti-
CD31 antibody were used to separate both cell types. This
technique allowed confirming that both cell types were
proliferating, although with significantly different growth
rates, being it higher for MSCs. This difference in cell
proliferation could explain the different percentage of both
cell types in coculture (Fig. 2). Moreover, MSCs growing in
coculture (CoMSC) showed a clearly higher cell growth rate as
compared with MSCs in monolayer. On one hand, this result
points towards the potential of HUVECs to stimulate MSCs
proliferation. On the other hand, MSCs could curtail ECs
capability for expansion due to their high proliferative capacity
in coculture. Notwithstanding that HUVECs in monoculture
presented a higher growth rate than in coculture, CoHUVECs
proliferated for a longer period than HUVECs alone. This ruled
out the possibility that CoHUVECs may be dying since, in fact,
there was an increases in cell number. Noteworthy, in
monoculture when endothelial cells are maintained at conflu-
ence for an extended period of time, they become tightly
packed but show no tendency to overlap or overgrow. Then,
when cell density becomes to high, cells start to detach and die
(Marin et al., 2001).
Another parameter that could influence cell proliferation
was the extracellular matrix produced, since an increase onone of its major components was detected (upregulation of
collagen type I). In parallel, a study was perform to validate
that the significant increase in CoMSC proliferation was indeed
related with HUVECs presence, and not with differences in
terms of cell seeding densities (CoMSCs cell seeding density
was 1500 cells/cm2 instead of 3000 cells/cm2 as the MSC
monoculture). For that purpose MSCs were seeded alone at
1500 cells/cm2, which allow comparing with CoMSC of the
same real “age” (having gone through the same cell divisions)
during the 21 days of culture (Fig. 2C). Although MSCs at lower
cell density presented a higher proliferation rate in the first
weak, in the following two weeks CoMSCs continued to exhibit
the highest proliferation (Fig. 2C), corroborating the potential
of HUVECs to stimulate MSCs proliferation.
It is well established that the cytoskeleton plays important
roles in cell morphology, adhesion, growth and signaling. The
actin network, one of the three components of the cytoskel-
eton, is of critical importance in the determination of the
mechanical properties of living cells. In this study, itwas shown
that the actin cytoskeleton changes from an apparently well-
organized structure, with long fine fibers running in parallel
along the cell axis in MSCs monocultures, to a more random
arrangement of the actin cytoskeleton in cocultures (Fig. 3A).
Yourek and colleagues observed this type of cytoskeleton
changes upon osteogenic differentiation (Yourek et al., 2007).
They further stated that this reorganization could be related
with the natural reaction of the actin cytoskeleton in bone
cells to the shear stress that occurs in vivo during bone
modeling/remodeling. Grellier et al. (2009a) also observed a
similar cell rearrangement in osteoprogenitor cells (HOPs)
cocultured with ECs (Grellier et al., 2009a). They further
observed HUVECsmigration along HOPs and suggested that the
193Phenotypic and proliferative modulation of hMSC via crosstalk with endothelial cellsdirect contact between the two cell types could stimulate the
release of chemotactic factors that, in turn, would stimulate
HUVEC migration.
To support the hypothesis that cytoskeleton changes of
CoMSC could be related with their osteogenic differentiation
in the presence of endothelial cells, further studies were
made. Consequently, ALP cytochemistry and activity, and
also gene expression analyzes of osteogenic markers, were
performed. ALP activity is considered an early osteogenic
marker since its expression increases from the beginning of cell
differentiation and increases throughout extracellular matrix
maturation (Stein et al., 1990). As shown in Fig. 3B therewas an
increased in the number of ALP stained cells in coculture
comparing to monoculture even after only 3 days, suggesting a
commitment of CoMSCs into the osteogenic lineage. The ALP
activity profiles and gene expression were assessed and both
support the previous data (Figs. 3C and 4B). The gene profile of
type I collagen, a protein of the extracellular matrix and the
main organic component of bone tissue, was also higher in
CoMSC (Fig. 4A). In order to further analyze osteogenic
commitment of CoMSC, gene expression of two other early
markers of osteogenic differentiation, Runx2 and bone sialo-
protein (BSP), was evaluated by real time quantitative RT-PCR
assay. Runx2, is an earlier transcription factor proven essential
for commitment to osteoblatogenesis. BSP is a major non-
collagenous extracellular matrix protein in bone and promotes
the initial formation of mineral crystals (Ganss et al., 1999;
Zhang et al., 2009). Both genes were significantly upregulated,
which further confirms the differentiation of CoMSC along the
osteoblastic lineage (Fig. 4C). Other gene that was investigated
was osteocalcin (OCN) that is a noncollagenous calcium-binding
bone protein and is considered a late-stage osteogenic
differentiation marker (Ilmer et al., 2009). OCN expression
did not increase and, even after 21 days, there was no
upregulation. Overall, the genetic profile obtained points
towards an osteogenic commitment of MSCs culture in the
presence of ECs, but cells were not fully mature.
The effect of the relative HUVECs-MSCs ratio was also
investigated. This aspect can be controversial since many
different combinationswere found in the literature: 4:1 (Santos
et al., 2009), 2:1 (Guillotin et al., 2004; Villars et al., 2002;
Grellier et al., 2009a; Guillotin et al., 2008; Grellier et al.,
2009c; Clarkin et al., 2008b), 1:1 (Hofmann et al., 2008; Kaigler
et al., 2005; Finkenzeller et al., 2006; Stahl et al., 2004;
Wenger et al., 2004; Fuchs et al., 2009a; Fuchs et al., 2009b;
Jones et al., 1995; Wang et al., 1997), 1:1.5 (Fuchs et al.,
2007), 6.5:1 (Unger et al., 2007), 3:1 (Villars et al., 2000), 1.5:1
(Ito et al., 2000) of endothelial and osteoblast-like cells,
respectively. Themajority of these coculture studies have used
higher amounts of endothelial cells than bone cells, although
themedium compositionwas often different. Moreover, among
these works only one mentions a preliminary cell ratio study to
justify the selected ratio used (Unger et al., 2007). Although
authors did not show any results, they stated that a ratio of EC:
osteoblasts between 5:1 an 10:1 resulted in the presence of
both cell types after 1 week of culture, whereas ratios of 1:1,
1:5 and 1:10 resulted in substantial reduction of EC number
after the same period. In the present work, a relative cell ratio
study was also performed, with an increasing on the relative
amount of HUVECs: 25%HUVEC-75%MSC, 50%HUVEC-50%MSC
and 75%HUVEC-25%MSC, to investigate how the different ratios
could influence cell behavior. Regarding metabolic activity(Fig. 5A), monoculture reaches themaximum at day 7, which is
probably related to a higherMSCproliferation. In the coculture,
in the following 2 weeks there was a significant increase in
metabolic activity, mostly related to a higher CoMSC prolifer-
ation, as observed earlier. This one-week difference may be
related to the decrease in cell number of ECs in the coculture
that was further compensated with CoMSC proliferation
(Fig. 5B). The cell quantification assay provided additional
information on the behavior of the two cell types at each cell
ratio throughout the time (Fig. 5B). As expected, higher initial
amounts of HUVECs led to a higher percentage of HUVECs in the
coculture at day 21. Additionally, HUVECs relative number
decreased throughout time, while MSCs increased using all the
three relative cell ratios tested. In short time studies the initial
cell seeding may not be essential, although for longer periods
the cell ratio in the coculture needs to be carefully evaluated.
Concerning ALP activity (Fig. 6A) no major differences were
found between the different cell ratios until the last week,
where the ratio with higher relative amounts of MSC presented
higher ALP activity.
Additionally, cell studies were also performed in the
presence of osteogenic media. This allowed assessing the
in vitro mineralization of MSC in contact with ECs due to
the presence of an inorganic phosphate source (beta-
glycerophosphate). It was possible to observemineral deposits
in the cell culture of all the ratios (Fig. 7). Moreover, cells in
osteogenic conditions showed some changes in cell morphol-
ogy comparing to cells in basal conditions (Fig. 7). However,
regarding ALP activity, no major differences were found
between basal and osteogenic conditions in all ratios (Fig. 6).
Collectively, the present findings demonstrate that, by
coculturing MSCswith HUVECs, there was not only an enhance-
ment of osteogenic differentiation, but also a significant
increase on MSCs proliferation. This augmentation in cell
proliferation occurred in the presence of ECs, independently of
relative cell ratios, but was favored by higher relative amounts
of HUVECs. The main conclusions drawn from this work may be
helpful for the development of a strategy for large-scale
production of mesenchymal stem cells committed into the
osteogenic lineage for tissue engineering applications, where a
high amount of cells is required. Further studies are being
carried out to assess the relevance of the present findings in an
in vivo scenario. Previous results fromour groupprovideda clear
indication that ECs are also able to induce the commitment of
MSCs into the osteogenic lineage in vivo. In fact, when both cell
types were cocultured within a 3Dmatrix and then implanted in
a rat femoral critical-sized defect, there was a significant
increase in mineralization compared with the implantation of
MSC alone (Grellier et al., 2009c). Additional studies are being
carried out to get further insight into cocultured cell behavior in
vivo, under different experimental conditions. In case of
success, that knowledge would be useful for developing
minimally invasive regenerative therapies using injectable 3D
matrices as (multi)cell delivery systems (Evangelista et al.,
2007; Grellier et al., 2009c; Bidarra et al., 2010; Fonseca et al.,
2011).
This work constitutes a step forward in the pursuit for a
better understanding of the interaction between these two
cell lines, which can easily find application in several other
tissue engineering approaches where vascularization is of
prime importance. To our knowledge, the current paper
showed for the first time that coculturing MSC with HUVECs
194 S.J. Bidarra et al.significantly increased MSCs proliferation, independently of
the relative cell ratio.
Materials and methods
Cell cultures
Human mesenchymal stem cells from bone marrow (MSCs,
Lonza) were cultured and expanded in MSCGM (MSC growth
medium, Lonza). For the experiments, cells were used at
passage 8 and cultured in basal medium: Dulbecco's modified
Eagle medium with low glucose (DMEM, Gibco), supplemented
with 10% v/v inactivated fetal bovine serum (FBS, Gibco) and
1% v/v penicillin/streptomycin (P/S, Gibco). The culture
medium was changed every other day.
Human umbilical vein endothelial cells (HUVECs, Scien-
Cell) were cultured in M199 medium (Gibco), supplemented
with 10% of inactivated fetal bovine serum (FBS) (Gibco),
0.1 mg/mL of heparin (Sigma) and 0.03 mg/mL of endothe-
lial cell growth supplement (ECGS) (Sigma-Aldrich). HUVECs
were used until passage 8 and harvested on 0.1% w/v gelatin-
coated tissue culture. The medium was renewed every 2 to
3 days until the cells reached confluence.
For cocultures, a pre-selection of the most adequate
medium was performed. Several commercial media were
tested, including Iscove Modified Dulbecco Medium (IMDM),
M199, DMEM and a mixture 1:1 of these last two media. Cell
behavior was analyzed in terms of metabolic activity and
total protein content along the time.
After medium selection, MSC and HUVEC monocultures
were seeded at a density of 3x103 cells/cm2 and cultured for
21 days. For cocultures both cell types were seeded at 1.5x103
cells/ cm2 (1:1), resulting in a final cell density of 3x103
cells/cm2. For all the studies the total initial cell densitywas of
3x103 cells/cm2. For control experiments MSCs monocultures
were seeded with a lower cell density (1500 cells/cm2, the
same MSC density used in the cocultures).
Cell metabolic activity
To measure metabolic activity a resazurin-based assay was
performed. Thismethod is based on the conversion of resazurin
to resorufin by metabolically active cells that result in the
generation of a fluorescent product. At different time points
themediumwas removed from thewells and resazurin (Sigma)
was added in fresh medium at a final concentration of 10%
(v/v). Then, cells were incubated at 37 °C for 4 h, after which
200 μL/well were transferred to a 96 well black plate and
fluorescence was measured (530 nmEx/590 nmEm) in a Spectra
Max Gemini XS (Molecular Devices).
Protein concentration
The bicinchoninic acid protein assay (BCA, Pierce) was used to
detect and quantify the total protein content, as recommended
by the manufacturer. Briefly, three samples of cell lysates for
each condition, obtained by brief sonication in ice with 1% v/v
Trition X-100, were incubatedwith the bicinchoninic acid (BCA)
working reagent for 1 h at 37 °C. Then, the absorbance was
read at 540 nm in a microplate reader (SLT Spectra).Effect of relative cell ratios on MSC behavior
The effect of MSCs and HUVECs relative ratios on MSCs
behavior was evaluated by testing the following cell combina-
tions: 25%HUVEC-75%MSC, 50%HUVEC-50%MSC and 75%HUVEC-
25%MSC. MSCs monocultures were used as a control and were
seeded at a cell density of 3x103 cells/cm2. Independently of
the cell ratio, cocultures were also prepared at the same total
density of 3x103 cells/cm2, and the percentage for each cell
typewas calculatedwith reference to that density. The studies
were carried on for 21 days.
To induce the formation of mineralized extracellular
matrix, studies were performed in the presence of osteo-
genic stimuli (further on designated as osteogenic medium):
basal medium (DMEM and M199 (1:1)) supplemented with
10 mM β-glycerophosphate (Sigma), 10-8 M dexamethasone
(Sigma) and 50 μg/mL ascorbic acid (Fluka).
Cell separation and quantification
At different time points, cells were detached from the well
plate and an aliquot of cell suspension was transferred to a
Neubauer chamber for total cell counting.
To quantify and further perform gene analysis on each cell
type after coculture, cells were separated by magnetic cell
sorting using magnetic beads coupled with an antibody
against CD31 (Invitrogen) (Grellier et al., 2009a). For this
purpose, cells in coculture were harvested by trypsin and
then incubated with anti-CD31 magnetic beads (at a ratio of
10:1 beads/HUVECs) for 30 min at 4 °C under gentle stirring.
Afterwards, the supernatant fraction containing the cocul-
tured MSCs (CoMSCs) was separated from the bead fraction,
which contained the cocultured HUVECs (CoHUVECs), using a
magnet device (Invitrogen).
Cell morphology
To analyze cell morphology, after fixation with 4% w/v
paraformaldehyde and permeabilization with 0.1% v/v Triton
X-100, cells were stained for F-actin (Alexa Fluor 488 phalloidin;
MolecularProbes) and for nuclei (4’,6-Diamidino-2-phenylindole
dihydrochloride, DAPI; Sigma) and then visualized under an
inverted fluorescence microscope (Axiovert 200 M, Zeiss).
Flow cytometry analysis
Flow cytometry studies were performed on MSCs mono-
cultures and on MSCs/HUVECs cocultures at different cell
ratios. The percentage of HUVECs in the cocultures was
estimated using anti-human CD31 (PECAM-1) antibody
labeled with FITC (BD Biosciences). Cell suspensions were
stained for 15 min, and for each day and ratio, 10,000 events
were analyzed in triplicate on a FACSCalibur flow cytometer
(Becton Dickenson). Data processing was performed using
FlowJo software 8.7.
Alkaline phosphatase (ALP) activity
For ALP cytochemistry cells were incubated in the dark for
1 h at 37 °C in Naphtol AS-MX phosphate/Fast Violet B salt
195Phenotypic and proliferative modulation of hMSC via crosstalk with endothelial cells(Sigma), as recommended by the manufacturer. After being
rinsed with deionized water and air-dried samples were
observed under an inverted microscope (Axiovert 200 M,
Zeiss).
For quantitative ALP analyses, cell lysates were obtained
by treatment with 1% v/v Triton X-100 under brief sonication
in ice, and then incubated with the chromogenic substrate
2 mM ρ–nitrophenol phosphate in 0.2 M bicarbonate buffer
(pH 10), 0.05% v/v Triton X-100, and 4 mM MgCl2 (Sigma) for
1 h at 37 °C. The reaction was stopped by adding 1 M NaOH
and absorbance was read at 405 nm in a microplate reader
(SLT Spectra). The amount of product was obtained from a
p-nitrophenol standard curve. The enzymatic activity was
normalized to total protein concentration, obtained using
the bicinchoninic acid protein assay (BCA, Pierce), and
expressed as nmol/min/mg protein.
Mineralization
For assessment of mineralization by von Kossa staining cells
were fixed with 3.7% v/v formaldehyde in PBS during 15 min.
Then, cells were incubated in 2.5 wt-% silver nitrate (Sigma)
for 30 min under UV light, followed by incubation in 5 wt-%
sodium thiosulfate (Aldrich) for 3 min. Finally, wells were
rinsed with deionized water and air-dried prior to observa-
tion under an optical microscope.
Phenotype analyses through mRNA expression
Total RNAwas extracted fromMSCs inmono- and cocultures, at
weekly time points, using the Total RNA isolation Kit
(Macherey-Nagel), as recommended by the manufacturer.
Subsequently, 1 μg of the total RNA was used as template for
single strand cDNA synthesis with the Superscript pre-
amplification system (Invitrogen) in a 20 μL final volume
containing 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 5 mM MgCl2,
10 mM DTT, 0.5 mM of each dATP, dCTP, dGTP and dTTP,
0.5 μg oligo(dT)12-18, and 50 U of reverse transcriptase. After
incubation at 42 °C for 50 min, the reaction was stopped at
70 °C for 15 min. After the cDNA synthesis reaction, qReal-
TimePCRwas carriedout in a total volumeof 25μL of amixture
containing 5 μL of cDNA diluted at a 1:80 ratio (corresponding
to 3.125 ng of total RNA), 200 nM of each forward and reverse
primers and 1x Mesa Green qPCR MaterMix Plus for Sybr Assay
(Eurogentec). Primers of ubiquitary ribosomic protein P0
forward: 5′ ATGCCCAGGGAAGACAGGGC 3′; reverse: 5′ CCAT-
CAGCACCACAGCCTTC 3′; type I collagen (COL I) forward: 5′
GGAATGAGGAGACTGGCAACC3′ and reverse 5′ TCAGCACCA
CCG ATG TCC AAA 3′; alkaline phosphatase (ALP) forward 5′
AGCCCTTCACTGCCATCCTGT 3′; reverse 5′ATTCTCTCGTTC
ACC GCC CAC 3′; transcription factor Runx2 forward 5′
GTGCCTAGGCGCATTTCA 3′ and reverse 5′ GCTCTTCTTACTGA-
GAGTGGAAGG 3′; osteocalcin (OCN) forward 5′ TGAGAGCCCT-
CACACTCCTC 3′ and reverse 5′ ACCTTTGCTGGACTCTGCAC 3′;
bone sialoprotein (BSP) forward 5′ CGATTTCCAGTTCAGGG-
CAGT 3′ and reverse 5′ CAACACTGGG CTATGGAGAG G 3′. qRT-
PCR experiments were run using an iQ5 (Bio-Rad) and analyzed
with the iCycler IQTM software. Relative quantification of gene
amplification by qRT-PCR was performed using the cycle
threshold (Ct) values and relative expression levels were
calculated as follows: 2^(Ct P0gene - Ct gene of interest). >Theexpression value for each target genewas normalized to the P0
value at each time point. Afterwards, the gene expression at
each day was normalized to day 0. For each PCR, samples were
analyzed in duplicate and three independent experiments
were performed.
Statistical analyses
Statistical analyses were performed using SigmaStat (Statis-
tical Software, STAT32 MFC Application). Statistical signif-
icance was assessed by using two way analysis of variance
(ANOVA) in conjunction with Tukey's test, pairwase multiple
comparison procedures. Differences were considerer statis-
tically significant when p values were lower than 0.05. All
data are presented as mean values±standard deviation.
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